Skip to main content
ConductScienceScienceDex

Moustafa Gabr

NIH Rank #1347
Unclaimed recordClaim profile
  • R01 Holder
  • Top 10% Funded
  • Early Career

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 16183802Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

FY2026 award categories

  • Radiology

NIH Funding · FY2024

Linked Award Amount
$4.5M
Full award amounts, FY2024
Award Records
5
Records listing this PI
Award-Linked Rank
#1,347
By linked amount among FY2024 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Moustafa Gabr. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2024 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2024 award records by amount

NIH award records listing Moustafa Gabr as a PI. Multi-PI records show the full award amount for context.

  • 1RF1AG084635-01A1RF1
    Small molecule inhibitors of CAPON-induced tau aggregation
    Weill Cornell Medicine
    $2M
    award amount
  • 1R01AG083512-01A1R01
    Discovery of first-in-class small molecule TREM2 ligands as therapeutics for Alzheimer's disease
    Weill Cornell Medicine
    $768.3K
    award amount
  • 1R01DK137299-01A1R01
    Optimization of small molecule immunomodulators as combination therapy for IBD
    Weill Cornell Medicine
    $672.4K
    award amount
  • 1R01CA293456-01R01
    Small molecule inhibitors of Slit2/Robo signaling as novel therapeutics for glioblastoma
    Weill Cornell Medicine
    $547.7K
    award amount
  • 1R01NS136524-01R01
    CHI3L1-targeted small molecules for glioblastoma
    Weill Cornell Medicine
    $502.6K
    award amount

Award organization

Organizations that administered FY2024 awards listing Moustafa Gabr as a PI.

FY2024 award administered by Weill Cornell Medicine (NY).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    Weill Cornell Medicine
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #1347
  6. 2024
    Entered Top 25% Nationally
    Ranked #1347
  7. 2024
    Entered Top 10% Nationally
    Ranked #1347
  8. 2025
    $5M Cumulative Funding
  9. 2025
    R01 Grant Holder

Explore further

Find collaborators for Moustafa Gabr

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →